• Journal of Radiation Protection and Research
• /
• 제23권1호
• /
• pp.7-15
• /
• 1998

몇 종류의 제염제에 대한 제염효과를 평가하기 위해 $^{60}Co$과 $^{137}Cs$에 의한 피부오염의 제염실험을 수행하였다. 본 연구에서는 인체피부 대신에 돼지피부를 활용하였으며, 피부오염용액으로는 $^{60}CoCl_2$와 $^{137}CsCl$ 용액을 사용하였다. 그리고 제염제로는 현재 사용되고 있는 비눗물, EDTA 외에 오염된 구조물의 표면오염 제거를 위해 원자력연구소에서 개발한 KAERICON과 본 연구를 통해 제조한 IOCON, TRICON 및 CHARCON 등을 이용하여 피부오염에 대한 제염을 실시하여 각 제염제의 제염효과를 평가하였다. 방사성물질의 피부침투정도를 파악하기 위하여 16시간동안 방사성물질을 시료표면에 점착시킨 후 감마선 측정을 통해 침투율을 평가하였으며, 이 실험에서 $^{137}Cs$의 경우 11.5%, $^{60}Co$의 경우 3.2% 정도가 피부로 침투됨을 알 수 있었다. 각 제염제의 제염효과를 평가해본 결과 KAERICON은 $^{137}Cs$에 대하여 최고 52.1%(제염계수 2.1)의 제염율을 나타내었으며, IOCON도 $^{137}Cs$에 대하여 비교적 좋은 제염율(제염계수 1.9)을 나타내었다. 그러나 $^{60}Co$에 대해서는 IOCON, CHARCON 모두 20%(제염계수 1.2) 미만의 제염율을 나타내었으며, KAERICON도 $^{60}Co$에 대해 낮은 제염율(제염계수 1.1)을 나타내었다. TRICON은 $^{137}Cs$에 대해 $1.6{\sim}1.8$의 제염계수를 나타내었으며, $^{60}Co$에 대해서는 $1.0{\sim}1.2$의 제염계수를 나타내었다.

• Toxicological Research
• /
• 제14권2호
• /
• pp.205-209
• /
• 1998

To evaluate immunotoxicity of skin decontamination kit(SDK) newly-developed in Agency for Defense Development(ADD), delayed contact hypersensitivity (maximization) test and passive cutaneous anaphylaxis(PCA) test of SDK were performed and the results were compared with those of M 291. In maximization test, sensitization reaction was induced by id injection (2.5 mg / 0.1 $\textrm{m}{\ell}$/ guinea pig or 2.5 mg+CFA/0.1 $\textrm{m}{\ell}$/guinea pig) and topical application (2.5 mg/$\textrm{m}{\ell}$/guinea pig) with SDK or M291 at an interval of 1 week, and 2 weeks later, challenged by topical application with 25 mg/$\textrm{m}{\ell}$/guinea pig. SDK and M291 did not induce any reactions, showing 0 point of sensitization score and 0% of sensitization rate. In conclusion, it is suggested that SDK and M291 do not induce delayed contact hypersensitivity. In PCA test, rats were administered id with mouse anti-SDK serum and challenged iv with a mixture of antigen SDK and Evan's blue. SDK did not induce blue spots at the injection sites of both high (2.5 mg/mouse) and low (1.25 mg/mouse) dose-induced antisera. In contrast, BSA, positive control produced spots larger than 5 mm in diameter at the injection sites of BSA-induced antiserum up to $2^2$ ~ $2^4$dilution. In conclusion, it is suggested that SDK do not induce IgE production and is not a PCA-reaction inducer.

• 한국의류학회지
• /
• 제46권5호
• /
• pp.836-847
• /
• 2022

This study establishes basic data for the development of a new Chemical, Biological, and Radioactive (CBR) protective clothing by selecting the ventilation position to optimize thermal comfort on the basis of the opening and closing of each part. Participants were eight men in their 20s who had previously worn CBR protective clothing. After vigorous exercise and perspiration, the microclimate of the clothing and skin temperature was measured. Results revealed that when the ventilation zipper was opened after exercising, the skin and clothing microclimate temperatures, which had increased during the exercise, decreased in the chest and shoulder blade regions. The clothing microclimate humidity decreased in the chest area. The change was greatest in the chest region; the skin temperature decreased by 0.2℃, the clothing microclimate temperature by 2.7℃, and the clothing microclimate humidity by 3.2%RH through ventilation. Thus, the opening that allows the exchange of accumulated heat and moisture while wearing the CBR protective clothing is efficient.

• Toxicological Research
• /
• 제14권2호
• /
• pp.217-226
• /
• 1998

SDK (skin decontamination kit) is new skin decontaminant which is developed by ADD (Agency for defence development). In this study, four-week toxicity of SDK was investigated using beagle dogs and Sprague-Dawley rats. The beagle dogs and Sprague-Dawley rats were dressed topically seven days per week for 28 days, with dosage of 0, 0.25, 0.8 and 1 g/kg/day. respectively. Animals treated with SDK did not cause any death and show any clinical signs. They did not show any significant changes of body weight, feed uptake and water consumption. They were not significantly different from the control group in urinalysis, ocular examination and histopathological examination. In hematological and serum biochemical assay, there were no-dose-defendent changes. Therefore, SDK was not indicated to have any toxic effect in the beagle dogs and Sprague-Dawley rats when it was dressed topically below the dosage 1 g/kg/day for four weeks.

• Toxicological Research
• /
• 제14권2호
• /
• pp.211-216
• /
• 1998

In order to evaluate the mutagenic potential of SDK(skin decontamination kit) produced by Agency for Defense Development(ADD), were performed Salmonella typhimurium reversion assay, chromosomal aberration test on chinese hamster ovarian cells and in vivo micronucleus assay using mouse bone marrow cells according to the established regulation of Korean Food and Drug Administration. In the reverse mutation test using Salmonella typhimurium TA98, TA100, TA1535 and TA1537 did not in-crease the number of revertant at any of the concentration tested in this study. SDK did not increase the number of cells having structural or numerical chromosome aberration in cytogenetic test. In mouse micronucleus test, no significant increase in the occurrence oj micro nucleated polychromatic erythrocytes were observed in ICR male mice intraperitoneally administered with SDK. These results indicate that SDK has no mutagenic effects under these experimental conditions.

• 한국안전학회지
• /
• 제24권4호
• /
• pp.47-52
• /
• 2009

이 연구는 Fluorouracil(5-FU)가 병원에서 암치료제로 쓰이는 세포독성약제의 한 종류이기 때문에 병원내부에 5-FU의 폭로 정도와 그 관리를 위한 가장 효율적인 세척약제를 조사하기 위한 것이다. 이러한 세포독성 약제실이나 종약학 병동에서 근무하는 실무자들은 세포독성약제로 오염된 표면에 빈번하게 접촉하게 되면 세포유전성이나 DNA손상에 대한 위험이 높게 된다. 따라서 이러한 약제의 세척제실험을 위하여 4가지 약제로서 시행한분해시험에서 0.5%(w/v) NaClO 용액만이 5-FU를 즉시 분해시켰으므로 이 용액은 오염표면의 잔유물을 분해시키는데 사용될 수 있다. 세포독성 약제실의 오염표면에서 확인된 농도범위는 2.0에서 $13.8{\mu}g/m^2$까지이고, 종약학 병동의 오염표면에서 측정한 농도범위는 5.39에서 $11.53{\mu}g/m^2$이었다. 5-FU와 같은 세포독성약제로부터 피부오염을 피하기 위하여 작업장의 노출허용기준과 같은 법적인 조치, 완벽한 표면세척제 및 보호구사용과 같은 엄격한 관리기준이 마련되어야 할 것이다.